How pharmaceuticals became patentable: The production and appropriation of drugs in the twentieth century

History and Technology

Volumn 24, Issue 2, 2008, Pages 99-106

  Gaudillière, Jean Paul ^a  

^a INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 40749085124     PISSN: 07341512     EISSN: 14772620     Source Type: Journal    
DOI: 10.1080/07341510701810906     Document Type: Editorial

References (25)

1. Bud, Robert (2007) Penicillin. Triumph and Tragedy, Oxford University Press, Oxford
2. Cassier, Maurice (2004) Brevets pharmaceutiques et santé publique en France: Oppositions et dispositifs spécifiques d'appropriation du medicament entre 1791 et 2004. Entreprise et histoire, pp. 29-47.
3. Clark, Ronald W. (1986) The Life of Ernst Chain, Penicillin and Beyond, Macmillan, London
4. Daston, Lorraine (1995) The Moral Economy of Science. Osiris, 10, pp. 2-24.
5. Etzkowitz, Henry and Webster, A. (1994) Science as Intellectual Property. Handbook of Science, Technology and Society, Sage, London
6. Foray, Dominique (2000) L'économie de la connaissance, La Découverte, Paris
7. Gaudillière, Jean-Paul (2006) La médecine et les sciences, 19ème-20ème siècles, La Découverte, Paris
8. Greene, Jeremy (2004) Attention to Details: Etiquettes and the Pharmaceutical Salesman in Postwar America. Social Studies of Science, 34, pp. 271-292.
9. de Haas, M. (1981) Brevets et medicaments en droit français et en droit européen, Litec, Paris
10. Heller, Michael and Eisenberg, R. (1998) Can Patent Deter Innovation? The Anticommons Tragedy in Biomedical Research. Science, 280, pp. 698-701.
11. Kohler, Robert (1994) Lords of the Fly, University of Chicago Press, Chicago
12. McLeod, Christine (1988) Inventing the Industrial Revolution: The English Patent System, 1660-1800, Cambridge University Press, Cambridge
13. Marks, Harry (1997) The Progress of Experiment, Cambridge University Press, Cambridge
14. Mowery, David and Sampat, B. N. (2001) University Patents, Patent Policies, and Patent Policy Debates, 1925-1980. Industrial and Corporate Change, 10, pp. 781-814.
15. Pamela, L. (1991) Invention, Authorship, Intellectual Property and the Origins of Patents. Technology and Culture, 32, pp. 846-884.
16. Polanyi, Michael (1944) Patent Reform. The Review of Economic Review, 11, pp. 61-76.
17. Polanyi, Michael (1962) Personal Knowledge, The University of Chicago Press, Chicago
18. Rasmussen, Nicolas (2004) The Moral Economy of the Drug Company-Medical Scientist Collaboration in Interwar America. Social Studies of Science, 34, pp. 161-185.
19. Simon, Jonathan (2005) Chemistry, Pharmacy and Revolution in France, 1777-1809, Ashgate, Aldershot
20. Swann, John (1988) Academic Scientists and the Pharmaceutical Industry, Johns Hopkins University Press, Baltimore
21. Tanner, Jakob (1998) The Swiss Pharmaceutical Industry: The Impact of Industrial Property Rights and the Trust in the Laboratory, 1907-1939. Determinants in the Evolution of the European Chemical Industry, 1900-1939, pp. 257-272. Kluwer, Dordrecht
22. Thomson, Edward P. (1991) Customs in Common, Merlin Press, London
23. Weisz, Georges (1995) The Medical Mandarins. The French Academy of Medicine in the 19th Century and the Early 20th Century, Oxford University Press, Oxford
24. (1978) Patent Policy: Government, Academic and Industry Concepts, American Chemical Society, Washington, DC
25. Wimmer, W. (1994) Wir haben fast immer etwas Neues. Gesundheitwesen und Innovationen der Pharma-Industrie in Deutschland, Duncker & Humblot, Berlin